SCHEMBL1492953

SCHEMBL1492953

CC(O)COc1cc(O)cc(C(=O)Nc2nccs2)c1

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 6/20 0.53
NPC1 O15118 4/20 0.53
SMN1; SMN2 Q16637 3/20 0.53
HPGD P15428 1/20 0.53
GCK P35557 9/20 0.52
MAPT P10636 2/20 0.51
BRD4 O60885 1/20 0.51
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
KCNH2 Q12809 1/20 0.48
HSD17B10 Q99714 2/20 0.48
ADORA2A P29274 4/20 0.47
ADORA2B P29275 1/20 0.47
ADORA1 P30542 1/20 0.47
MAPK1 P28482 1/20 0.47
POLB P06746 1/20 0.47
ESR2 Q92731 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1426929 0.85 GCK (0.64) RAB9ANPC1SMN1; SMN2HPGDGCK
SCHEMBL2664728 0.84 GCK (0.60) RAB9ANPC1SMN1; SMN2HPGDGCK
SCHEMBL13891667 0.84 GCK (0.74) RAB9ANPC1SMN1; SMN2HPGDGCK
SCHEMBL1146562 0.84 GCK (0.74) RAB9ANPC1SMN1; SMN2HPGDGCK
SCHEMBL1426992 0.83 GCK (0.67) RAB9ANPC1SMN1; SMN2HPGDGCK
SCHEMBL1493685 0.83 GCK (0.67) RAB9ANPC1SMN1; SMN2HPGDGCK
SCHEMBL1146565 0.80 RAB9A (0.54) RAB9ANPC1SMN1; SMN2HPGDGCK
SCHEMBL2664748 0.80 GCK (0.64) RAB9ANPC1SMN1; SMN2HPGDGCK
SCHEMBL2176809 0.80 RAB9A (0.56) RAB9ANPC1SMN1; SMN2HPGDGCK
SCHEMBL1426952 0.79 GCK (0.58) RAB9ANPC1SMN1; SMN2HPGDGCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2301929-A1 Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes AstraZeneca AB (Publ) (SE) 2011-03-30 EP disclosed